Covista Inc. (CVSA)
Covista Inc. (CVSA) Stock Price, Analysis & Data
| Bid | 100 |
| Market Cap | 4.49B |
| Revenue (ttm) | 1.95B |
| Net Income (ttm) | 267.38M |
| Beta | 0.62 |
| EPS (ttm) | 7.49 |
| PE Ratio (ttm) | 17.61 |
| Forward PE | 13.18 |
| P/B (ttm) | 3.10 |
| P/S (ttm) | 2.30 |
| Earnings Date | Oct 29, 2026 |
| Ask | 138.5 |
| Volume | 221,505 |
| Avg. Volume (20D) | 342,529 |
| Open | 130.14 |
| Previous Close | 128.22 |
| Day's Range | 128.30 - 133.98 |
| 52-Week Range | 86.97 - 156.26 |
| Analyst | Strong Buy |
| Price Target | 157.5 (19.42%) |
| Dividends | n/a |
| Ex-Dividend Date | Nov 30, 2016 |
About CVSA
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, bus...
Financial Performance
In 2026, Covista's revenue was 1.95B, an increase of 9.27% compared to the previous year's 1.79B. Earnings were 251.57M, an increase of 6.12%.
Financial StatementsAnalyst Forecast
According to 4 analyst ratings, the average rating for CVSA stock is "Strong Buy". The 12-month stock price forecast is 157.5, which is upside of 19.42% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
